Effects of escitalopram on the regulation of brain‐derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Escitalopram (ES‐CIT) is a widely used, highly specific antidepressant. Until now there has been very little evidence on how this drug under pathological conditions affects an important feature within the pathophysiology of stress‐related disorders such as depression: the endogenous neurotrophins. By using a well‐characterized rat model in which chronic stress induces depressive‐like behavior, the levels of neurotrophins brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were determined in representative brain regions and serum using a highly sensitive improved fluorometric two‐site ELISA system. There was a significant increase of BDNF in the left and right cortices after stress treatment (twofold increase) that was reversed by application of ES‐CIT. An ES‐CIT‐dependent NGF reduction in stressed rats was detectable in the right cortex only (P= 0.027). The left hippocampus revealed significantly higher amounts of BDNF (2.5‐fold increase) protein than the right hippocampus. These interhemispheric differences were unrelated to stress or ES‐CIT treatment in all animals. BDNF and NGF of the frontal cortex, cerebellum, and serum did not change between the study groups. There was a negative correlation between body weight and serum BDNF, independent of stress or ES‐CIT treatment. In conclusion, BDNF and NGF show substantial changes in this rodent model of chronic social stress, which is susceptible to antidepressant treatment with ES‐CIT and therefore may constitute a neurobiological correlate for the disease. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“…other SSRIs and also noradrenalin reuptake inhibitors and monoamine oxidase inhibitors have been shown mostly to up-regulate BDNF mRNA and protein (Nibuya et al., 1995, 1996; Russo-Neustadt et al., 1999; Coppell et al., 2003; Dias et al., 2003; Xu et al., 2003; De et al., 2004; Vinet et al.,…”
BackgroundNeurobiology of emotion perception II: implications for major psychiatric disorders
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00171-9 · Cited by 1,736
Frontal EEG asymmetry as a moderator and mediator of emotion
Coan, J. A., & Allen, J. J. B. (2004) · Biological Psychology · doi:10.1016/j.biopsycho.2004.03.002 · Cited by 1,426
NEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337 · cited 1×
“DOI: 10.1002/jnr.22080 ' 2009 Wiley-Liss, Inc. Kerr et al., 1999; McAllister et al., 1999), neurotrophins have received increasing attention, insofar as their dysregulation might be responsible for the inappropriate adaptive neuronal response to stress with pathological consequences, such as…”
BackgroundInfluentialDecreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232 · cited 3×
“Because alteration of NGF and BDNF blood levels after stress have been controversial (Aloe et al., 1994; Karege et al., 2002; Lang et al., 2004a; Lommatzsch et al., 2006; Ziegenhorn et al., 2007), serum NGF and BDNF concentrations were determinated by ELISA.”
BackgroundMethodSen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 1×
“An increase of cerebral BDNF concentration in response to stress seems to be counterintuitive, in that the traditional ‘‘neurotrophin hypothesis of depression’’ assumes a stress-related hippocampal decrease of BDNF expression (for recent review see Martinowich et al., 2007).”
BackgroundConner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., & Varon, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02295.1997 · Cited by 1,097 · cited 1×
“Owing to the fact that BDNF exerts a significant axonal transport, levels of BDNF mRNA and its encoding protein often do not correlate at all (Conner et al., 1997; Jacobsen and Mork, 2004).”
BackgroundInteraction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793 · cited 1×
“A reciprocal interaction of the serotonergic system and BDNF has recently been reviewed (Martinowich and Lu, 2007).”
BackgroundNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Anhedonia and motivational deficits in rats: Impact of chronic social stress
Rygula, R., Abumaria, N., Flügge, G., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.009 · Cited by 554
Self-citationDalton, S. O., Johansen, C., Mellemkjær, L., Sørensen, H. T., Nørgård, B., & Olsen, J. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.59 · Cited by 389
Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
Gonul, A. S., Akdeniz, F., Taneli, F., Donat, O., Eker, Ç., & Vahip, S. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0578-6 · Cited by 375 · cited 8×
“Although there are considerable differences in the BDNF levels between studies, they all point to decreased serum BDNF in depression (Karege et al., 2002; Aydemir et al., 2006; Sen et al., 2008) that were reversed to healthy control levels after treatment with various SSRIs (Gonul et al., 2005; Aydemir et al., 2006; H…”
BackgroundInfluentialHayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
Roceri, M., Cirulli, F., Pessina, C., Peretto, P., Racagni, G., & Riva, M. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.011 · Cited by 317 · cited 1×
“…(Nibuya et al., 1995; Smith et al., 1995b; Ueyama et al., 1997; Journal of Neuroscience Research Barrientos et al., 2003; Pizarro et al., 2004; Roceri et al., 2004), there is a considerable amount of research that denies (Schulte-Herbrüggen et al., 2006) or even opposes (Branchi et al.,…”
BackgroundDias, B. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00198-9 · Cited by 274 · cited 2×
“Several other SSRIs and also noradrenalin reuptake inhibitors and monoamine oxidase inhibitors have been shown mostly to up-regulate BDNF mRNA and protein (Nibuya et al., 1995, 1996; Russo-Neustadt et al., 1999; Coppell et al., 2003; Dias et al., 2003; Xu et al., 2003; De et al., 2004; Vinet et al., 2004).”
BackgroundThe Clinical Pharmacokinetics of Escitalopram
Rao, N. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746040-00002 · Cited by 256
Barrientos, R. M., Sprunger, D. B., Campeau, S., Higgins, E. A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00564-5 · Cited by 251 · cited 7×
“…that is associated with a depressive phenotype (Nibuya et al., 1995; Smith et al., 1995b; Ueyama et al., 1997; Journal of Neuroscience Research Barrientos et al., 2003; Pizarro et al., 2004; Roceri et al., 2004), there is a considerable amount of research that denies (Schulte-Herbrüggen et…”
BackgroundInfluentialde Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., Murray, T. K., Gaillard, J. P., Deville, C., Xhenseval, V., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.054 · Cited by 249 · cited 2×
“Several other SSRIs and also noradrenalin reuptake inhibitors and monoamine oxidase inhibitors have been shown mostly to up-regulate BDNF mRNA and protein (Nibuya et al., 1995, 1996; Russo-Neustadt et al., 1999; Coppell et al., 2003; Dias et al., 2003; Xu et al., 2003; De et al., 2004; Vinet et al., 2004).”
BackgroundXu, H., Steven Richardson, J., & Li, X.-M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300009 · Cited by 167 · cited 2×
“Several other SSRIs and also noradrenalin reuptake inhibitors and monoamine oxidase inhibitors have been shown mostly to up-regulate BDNF mRNA and protein (Nibuya et al., 1995, 1996; Russo-Neustadt et al., 1999; Coppell et al., 2003; Dias et al., 2003; Xu et al., 2003; De et al., 2004; Vinet et al., 2004).”
BackgroundEffects of fluoxetine on behavioral deficits evoked by chronic social stress in rats
RYGULA, R., ABUMARIA, N., DOMENICI, E., HIEMKE, C., & FUCHS, E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.017 · Cited by 126 · cited 3×
“Therefore, rats were subjected to chronic social defeat, as described previously (Rygula et al., 2005, 2006a), and in parallel were treated with the antidepressant ES-CIT for a period of 4 weeks.”
BackgroundMethodResultSelf-citationTwo types of cholinergic projections to the rat amygdala
Heckers, S., & Mesulam, M.-M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90252-6 · Cited by 105
Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats
Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000186631.53851.71 · Cited by 104
Self-citation
Cited by
Larsen, M. H., Mikkelsen, J. D., Hay-Schmidt, A., & Sandi, C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.01.005 · Cited by 165
“However, nowadays, the reported effects of CUS are contentious as several studies also have reported no effects or even increased BDNF levels in the hippocampus following exposure to chronic stress (Allaman et al., 2008; Bergstrom et al., 2008; Lee et al., 2006; Lucca et al., 2008; Schulte-Herbruggen et al., 2009; Vit…”
BackgroundNeurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150
Araya-Callís, C., Hiemke, C., Abumaria, N., & Flugge, G. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2741-x · Cited by 109
Self-citationZhong, H., Haddjeri, N., & Sánchez, C. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2463-5 · Cited by 105
“In a rat chronic stress model with a resident–intruder paradigm, BDNF levels doubled in the cerebral cortex after 5 weeks of stress, and this was prevented by escitalopram administration during the last 4 weeks (Schulte-Herbruggen et al. 2009).”
Dionisie, V., Ciobanu, A. M., Toma, V. A., Manea, M. C., Baldea, I., Olteanu, D., Sevastre-Berghian, A., Clichici, S., Manea, M., Riga, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147483 · Cited by 78
Metadata
- Authors
- Schulte‐Herbrüggen, O., Fuchs, E., Abumaria, N., Ziegler, A., Danker‐Hopfe, H., Hiemke, C., & Hellweg, R.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2009-04-09
- Volume
- 87
- Issue
- 11
- Pages
- 2551-2560
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2168738523
- Cited by
- 51
- References
- 24
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.